• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through February 2024

Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through February 2024

by Truveta staff | Mar 18, 2024 | Research

Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout February 2024 (-20.0%) compared to January 2024. While COVID- and influenza-associated hospitalizations decreased (-26.5% and -22.7%), all other respiratory viruses...
Case study: Assessing the comparative safety of novel pulmonary embolism treatments

Case study: Assessing the comparative safety of novel pulmonary embolism treatments

by Truveta staff | Mar 11, 2024 | Research

Each year, approximately 900,000 patients in the US are affected by a pulmonary embolism (PE), a blood clot causing a blockage in one or more pulmonary arteries in the lungs. PE is a leading cause of in-hospital death in the US, and acute PE – a sudden blockage...
Outcomes and disparities for patients with aortic stenosis, classified by echocardiogram data

Outcomes and disparities for patients with aortic stenosis, classified by echocardiogram data

by Truveta Research | Mar 6, 2024 | Research, Research Insights

Disparities in time to treatment and treatment outcomes exist for people with severe aortic stenosis receiving TAVR and SAVR procedures. We studied the rate of people who receive TAVR, SAVR, aortic valve repair, and aortic balloon valvuloplasty procedures and time to...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through January 2024

Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through January 2024

by Truveta staff | Feb 23, 2024 | Research

Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout January 2024 (-35.3%) compared to December 2023. The largest decreases were seen in parainfluenza virus- (-49.0%), RSV- (-48.0%), and influenza-associated (-41.6%)...
Using echocardiogram data to classify aortic stenosis severity

Using echocardiogram data to classify aortic stenosis severity

by Truveta Research | Feb 22, 2024 | Research, Research Insights

Aortic stenosis – the narrowing of the valve between the lower left heart chamber (left ventricle) and the aorta – is commonly diagnosed with an echocardiogram and staged according to the disease progression. However, it’s a difficult condition to study across large...
Thin ice and slippery snow: Winter injury trends

Thin ice and slippery snow: Winter injury trends

by Truveta Research | Feb 7, 2024 | Research, Research Insights

We found 13.1 emergency department visits for falls on snow or ice per 10,000 emergency department visits during wintery months; with 3x higher rates happening in states with freezing temperatures during the winters compared to states with milder winters. Wrist...
« Older Entries
Next Entries »

Share this


Recent posts

  • Completing the evidence picture with linked EHR and closed claims data
  • Truveta recognized on national and Seattle LinkedIn Top Startup 2025 lists
  • AI and imaging open new avenues for studying body composition at scale

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.